Desmopressin Acetate Patent Expiration
Desmopressin Acetate was first introduced by Ferring Pharmaceuticals Inc
Desmopressin Acetate Patents
Given below is the list of patents protecting Desmopressin Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Noctiva | US11419914 | Safe desmopressin administration | Jun 15, 2030 | Acerus Pharms |
| Noctiva | US9539302 | Safe desmopressin administration | Jun 15, 2030 | Acerus Pharms |
| Nocdurna | US9974826 | Methods comprising desmopressin | Apr 13, 2030 | Ferring Pharms Inc |
| Nocdurna | US10137167 | Methods comprising desmopressin | May 21, 2029 | Ferring Pharms Inc |
| Nocdurna | US11020448 | Methods comprising desmopressin | May 21, 2029 | Ferring Pharms Inc |
| Nocdurna | US11963995 | Methods comprising desmopressin | May 21, 2029 | Ferring Pharms Inc |
| Noctiva | US7799761 | Pharmaceutical compositions including low dosages of desmopressin |
Sep 26, 2024
(Expired) | Acerus Pharms |
| Nocdurna | US7560429 | Orodispersible dosage forms of desmopressin acetate |
Feb 02, 2024
(Expired) | Ferring Pharms Inc |
| Nocdurna | US7947654 | Pharmaceutical formulations |
Dec 29, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US8802624 | Methods of treatment using orodispersible desmopressin pharmaceutical formulations |
Dec 29, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US10307459 | Pharmaceutical formulations of desmopressin |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US9220747 | Methods using desmopressin acetate in orodispersible form |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US9504647 | Pharmaceutical formulations of desmopressin |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Nocdurna | US9919025 | Pharmaceutical formulations of desmopressin |
May 07, 2023
(Expired) | Ferring Pharms Inc |
| Noctiva | US7405203 | Pharmaceutical compositions including low dosages of desmopressin |
May 06, 2023
(Expired) | Acerus Pharms |
| Noctiva | US7579321 | Pharmaceutical compositions including low dosages of desmopressin |
May 06, 2023
(Expired) | Acerus Pharms |
| Ddavp | US7022340 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
Apr 30, 2023
(Expired) | Ferring Pharms Inc |
| Desmopressin Acetate | US7022340 | Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
Apr 30, 2023
(Expired) | Ferring |
| Ddavp | US5674850 | High purity desmopressin produced in large single batches |
Dec 23, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5674850 | High purity desmopressin produced in large single batches |
Dec 23, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp | US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp | US5763407 | High-purity desmopressin produced in large single batches |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5482931 | Stabilized pharmaceutical peptide compositions |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5500413 | Process for manufacture of 1-deamino-8-D-arginine vasopressin |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
| Ddavp (needs No Refrigeration) | US5763407 | High-purity desmopressin produced in large single batches |
Jun 29, 2013
(Expired) | Ferring Pharms Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desmopressin Acetate's patents.
Latest Legal Activities on Desmopressin Acetate's Patents
Given below is the list recent legal activities going on the following patents of Desmopressin Acetate.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical | 30 Apr, 2018 | US7022340(Litigated) |
| Maintenance Fee Reminder Mailed Critical | 13 Nov, 2017 | US7022340(Litigated) |
| Change in Power of Attorney (May Include Associate POA) Critical | 30 May, 2014 | US7022340(Litigated) |
| Recordation of Patent Grant Mailed Critical | 04 Apr, 2006 | US7022340(Litigated) |
| Patent Issue Date Used in PTA Calculation Critical | 04 Apr, 2006 | US7022340(Litigated) |
| Issue Notification Mailed Critical | 15 Mar, 2006 | US7022340(Litigated) |
| Dispatch to FDC | 03 Mar, 2006 | US7022340(Litigated) |
| Printer Rush- No mailing | 02 Feb, 2006 | US7022340(Litigated) |
| Mail Miscellaneous Communication to Applicant | 02 Feb, 2006 | US7022340(Litigated) |
| Miscellaneous Communication to Applicant - No Action Count | 31 Jan, 2006 | US7022340(Litigated) |
Desmopressin Acetate's Family Patents
Explore Our Curated Drug Screens
Desmopressin Acetate Generic API Manufacturers
Several generic applications have been filed for Desmopressin Acetate. The first generic version for Desmopressin Acetate was by Meitheal Pharmaceuticals Inc and was approved on Oct 15, 1997. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Mar 21, 2024.
Given below is the list of companies who have filed for Desmopressin Acetate generic, along with the locations of their manufacturing plants worldwide.
1. ABHAI LLC
Abhai Llc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Abhai Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG | tablet | Prescription | ORAL | AB | Jan 28, 2019 |
| 0.2MG | tablet | Prescription | ORAL | AB | Jan 28, 2019 |
2. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2005 |
| 0.1MG | tablet | Discontinued | ORAL | N/A | Jul 1, 2005 |
3. AM REGENT
American Regent Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Discontinued | INJECTION | N/A | Feb 14, 2019 |
4. APOTEX
Apotex Inc has filed for 1 generic for Desmopressin Acetate. This 0.01mg/spray version comes by the name DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION). Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01MG/SPRAY
(reference standard) | spray, metered | Prescription | NASAL | AB | Jan 27, 2005 |
Manufacturing Plant Locations New
Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||
| Canada |
| |||||||||||||
| India |
| |||||||||||||
5. APOTEX INC
Apotex Inc Etobicoke Site has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG | tablet | Prescription | ORAL | AB | Mar 7, 2006 |
| 0.2MG | tablet | Prescription | ORAL | AB | Mar 7, 2006 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
6. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2MG | tablet | Prescription | ORAL | AB | Mar 21, 2024 |
| 0.1MG | tablet | Prescription | ORAL | AB | Mar 21, 2024 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
7. BAUSCH
Bausch Health Us Llc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Bausch.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01MG/SPRAY
(reference standard) | spray, metered | Prescription | NASAL | AB | Jan 25, 1999 |
Manufacturing Plant Locations New
Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||
| Canada |
| |||||||||||||||||||||||||||
8. BEDFORD
Bedford Laboratories Div Ben Venue Laboratories Inc has filed for 1 generic for Desmopressin Acetate. This 0.004mg/ml version comes by the name DESMOPRESSIN ACETATE PRESERVATIVE FREE. Given below are the details of the strengths of this generic introduced by Bedford.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Discontinued | INJECTION | N/A | Feb 18, 2000 |
Manufacturing Plant Locations New
Bedford's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bedford as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||
9. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Aug 19, 2022 |
10. GLAND
Gland Pharma Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Gland.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Mar 20, 2023 |
Manufacturing Plant Locations New
Gland's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Gland as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
11. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Nov 16, 2022 |
12. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG | tablet | Prescription | ORAL | AB | May 28, 2015 |
| 0.2MG | tablet | Prescription | ORAL | AB | May 28, 2015 |
13. HERITAGE PHARMA
Heritage Pharma Labs Inc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Heritage Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG | tablet | Prescription | ORAL | AB | May 26, 2017 |
| 0.2MG | tablet | Prescription | ORAL | AB | May 26, 2017 |
Manufacturing Plant Locations New
Heritage Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Heritage Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
14. HOSPIRA
Hospira Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Discontinued | INJECTION | N/A | Aug 28, 2000 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
15. IMPAX LABS INC
Impax Laboratories Inc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG | tablet | Discontinued | ORAL | N/A | Jan 25, 2006 |
| 0.2MG | tablet | Discontinued | ORAL | N/A | Jan 25, 2006 |
16. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Oct 15, 1997 |
17. NATCO PHARMA USA
Natco Pharma Usa Llc has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Natco Pharma Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.1MG | tablet | Discontinued | ORAL | N/A | Jun 27, 2014 |
| 0.2MG | tablet | Discontinued | ORAL | N/A | Jun 27, 2014 |
18. NOVAST LABS
Novast Laboratories Ltd has filed for 2 different strengths of generic version for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2MG | tablet | Prescription | ORAL | AB | Jun 6, 2019 |
| 0.1MG | tablet | Prescription | ORAL | AB | Jun 6, 2019 |
19. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Aug 22, 2017 |
20. SUN PHARM
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desmopressin Acetate. This 0.01mg/spray version comes by the name DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION). Given below are the details of the strengths of this generic introduced by Sun Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01MG/SPRAY | spray, metered | Discontinued | NASAL | N/A | Dec 23, 2013 |
Manufacturing Plant Locations New
Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||||
| India |
| |||||||||||||||||||||||||||||
21. SUN PHARM INDS
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01% | solution | Discontinued | NASAL | N/A | Apr 12, 2012 |
22. SUN PHARM INDS LTD
Sun Pharmaceutical Industries Ltd has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Jan 25, 2013 |
23. UBI
Ubi Pharma Inc has filed for 1 generic for Desmopressin Acetate. Given below are the details of the strengths of this generic introduced by Ubi.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.004MG/ML | injectable | Prescription | INJECTION | AP | Sep 17, 2020 |
24. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Desmopressin Acetate. This 0.01mg/spray version comes by the name DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION). Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.01MG/SPRAY | spray, metered | Prescription | NASAL | AB | Oct 3, 2017 |